Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1.
作者信息
Coffin Stephanie L, Durham Mark A, Nitschke Larissa, Xhako Eder, Brown Amanda M, Revelli Jean-Pierre, Villavicencio Gonzalez Esmeralda, Lin Tao, Handler Hillary P, Dai Yanwan, Trostle Alexander J, Wan Ying-Wooi, Liu Zhandong, Sillitoe Roy V, Orr Harry T, Zoghbi Huda Y
出版信息
Neuron. 2023 Mar 15;111(6):915. doi: 10.1016/j.neuron.2023.02.030.
Abstract
摘要
相似文献
1
Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1.ATXN1-CIC复合物的破坏揭示了其他核ATXN1相互作用蛋白在1型脊髓小脑共济失调中的作用。
Neuron. 2023 Mar 15;111(6):915. doi: 10.1016/j.neuron.2023.02.030.
2
Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1.破坏 ATXN1-CIC 复合物揭示了核 ATXN1 相互作用蛋白在脊髓小脑共济失调 1 型中的作用。
Neuron. 2023 Feb 15;111(4):481-492.e8. doi: 10.1016/j.neuron.2022.11.016. Epub 2022 Dec 27.
3
ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.ATXN1-CIC 复合物通过获得性功能机制成为脊髓小脑共济失调 1 型小脑病理学的主要驱动因素。
Neuron. 2018 Mar 21;97(6):1235-1243.e5. doi: 10.1016/j.neuron.2018.02.013. Epub 2018 Mar 8.
4
Structural basis of protein complex formation and reconfiguration by polyglutamine disease protein Ataxin-1 and Capicua.多聚谷氨酰胺疾病蛋白 Ataxin-1 和 Capicua 形成和重排蛋白复合物的结构基础。
Genes Dev. 2013 Mar 15;27(6):590-5. doi: 10.1101/gad.212068.112.
5
Structural basis of the phosphorylation dependent complex formation of neurodegenerative disease protein Ataxin-1 and RBM17.神经退行性疾病蛋白 Ataxin-1 和 RBM17 磷酸化依赖性复合物形成的结构基础。
Biochem Biophys Res Commun. 2014 Jul 11;449(4):399-404. doi: 10.1016/j.bbrc.2014.05.063. Epub 2014 May 22.
6
ATXN1 protein family and CIC regulate extracellular matrix remodeling and lung alveolarization.ATXN1 蛋白家族和 CIC 调节细胞外基质重塑和肺肺泡化。
Dev Cell. 2011 Oct 18;21(4):746-57. doi: 10.1016/j.devcel.2011.08.017.
7
An out-of-frame overlapping reading frame in the ataxin-1 coding sequence encodes a novel ataxin-1 interacting protein.在共济失调蛋白 1 编码序列中存在一个移码框外重叠阅读框，它编码了一个新的共济失调蛋白 1 相互作用蛋白。
J Biol Chem. 2013 Jul 26;288(30):21824-35. doi: 10.1074/jbc.M113.472654. Epub 2013 Jun 12.
8
ATXN1 N-terminal region explains the binding differences of wild-type and expanded forms.ATXN1 N 端结构域解释了野生型和扩展型结合的差异。
BMC Med Genomics. 2019 Oct 26;12(1):145. doi: 10.1186/s12920-019-0594-4.
9
Antisense Oligonucleotide Therapeutic Approach for Suppression of Ataxin-1 Expression: A Safety Assessment.抑制ataxin-1表达的反义寡核苷酸治疗方法：安全性评估。
Mol Ther Nucleic Acids. 2020 Sep 4;21:1006-1016. doi: 10.1016/j.omtn.2020.07.030. Epub 2020 Jul 25.
10
Partial loss of Tip60 slows mid-stage neurodegeneration in a spinocerebellar ataxia type 1 (SCA1) mouse model.Tip60 的部分缺失可减缓脊髓小脑共济失调 1 型 (SCA1) 小鼠模型的中期神经退行性变。
Hum Mol Genet. 2011 Jun 1;20(11):2204-12. doi: 10.1093/hmg/ddr108. Epub 2011 Mar 22.
引用本文的文献
1
Multiplatform molecular analyses reveal two molecular subgroups of NF2-related schwannomatosis vestibular schwannomas with distinct tumour microenvironment and therapeutic vulnerabilities.多平台分子分析揭示了与神经纤维瘤病2型相关的前庭神经鞘瘤的两个分子亚组，它们具有不同的肿瘤微环境和治疗易感性。
Acta Neuropathol. 2025 May 9;149(1):47. doi: 10.1007/s00401-025-02883-6.
2
CRISPR-Cas9-directed gene therapy for spinocerebellar ataxia type 1.用于1型脊髓小脑共济失调的CRISPR-Cas9导向基因疗法。
Mol Ther Nucleic Acids. 2024 Nov 14;35(4):102377. doi: 10.1016/j.omtn.2024.102377. eCollection 2024 Dec 10.
3
Construction and validation of a synthetic phage-displayed nanobody library.合成噬菌体展示纳米抗体文库的构建与验证
Korean J Physiol Pharmacol. 2024 Sep 1;28(5):457-467. doi: 10.4196/kjpp.2024.28.5.457.
4
Cerebellar dysfunction in rodent models with dystonia, tremor, and ataxia.患有肌张力障碍、震颤和共济失调的啮齿动物模型中的小脑功能障碍。
Dystonia. 2023;2. doi: 10.3389/dyst.2023.11515. Epub 2023 Dec 8.
5
Dosage sensitivity to Pumilio1 variants in the mouse brain reflects distinct molecular mechanisms.在小鼠大脑中，对 Pumilio1 变异体的剂量敏感性反映了不同的分子机制。
EMBO J. 2023 Jun 1;42(11):e112721. doi: 10.15252/embj.2022112721. Epub 2023 Apr 18.
Zotero 插件